p-Synephrine ameliorates non-alcoholic fatty liver disease by regulating liver-adipose axis via AMPK/NF-kappa B pathway

This investigation proposed that p-synephrine had the potential to ameliorate HFD-induced NAFLD by regulating liver-adipose axis through AMPK/NF-κB pathway.

Authors

Institutions

Publication Details

Journal
Journal of Ethnopharmacology
Published
2025-04-26
DOI
https://doi.org/10.1016/j.jep.2025.119890
Citations
5
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
6.77
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

p-Synephrine ameliorates non-alcoholic fatty liver disease by regulating liver-adipose axis via AMPK/NF-kappa B pathway

Wei‐Feng Cai, Chunyan Shen, Qiang Liu, Cuiping Jiang et al.
5 citations
Journal of Ethnopharmacology
Liver Disease Diagnosis and Treatment
6.77
article

p-Synephrine ameliorates non-alcoholic fatty liver disease by regulating liver-adipose axis via AMPK/NF-kappa B pathway

Wei‐Feng Cai, Chunyan Shen, Qiang Liu, Cuiping Jiang, Qi-Cong Chen, Yankui Yi, Qian Ni, Li Liu
article en
5 citations

Abstract

This investigation proposed that p-synephrine had the potential to ameliorate HFD-induced NAFLD by regulating liver-adipose axis through AMPK/NF-κB pathway.

Journal of EthnopharmacologyVol. 348
TCM-Intigrated Cancer Center of Southern Medical University (CN), Southern Medical University (CN)
Good health and well-being
Openalex Percentile: Top 3%
Liver Disease Diagnosis and Treatment
6.77
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.